ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.232,34
-0,38%
S&P 500
6.021,63
0,57%
Dow Jones
44.860,31
0,28%
Euro vs US Dollar
1,05115
0,20%
Bitcoin
93.255,17
1,39%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. VYNE Therapeutics Inc (VYNE)

  7. VYNE Therapeutics Inc (VYNE) News

VYNE

VYNE Therapeutics (VYNE)

VYNE Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:VYNE
DatumZeitQuelleÜberschriftSymbolFirma
14/11/202421h34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
12/11/202422h06Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:VYNEVYNE Therapeutics Inc
12/11/202422h01Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:VYNEVYNE Therapeutics Inc
07/11/202422h07Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
07/11/202414h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
02/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
02/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
02/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
02/10/202422h15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
12/09/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
14/08/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
14/08/202414h04Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
04/06/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
09/05/202422h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VYNEVYNE Therapeutics Inc
09/05/202414h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
01/03/202423h16Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:VYNEVYNE Therapeutics Inc
01/03/202423h15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VYNEVYNE Therapeutics Inc
29/02/202414h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
02/02/202415h42Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202423h01Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
03/01/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VYNEVYNE Therapeutics Inc
15/12/202323h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
15/12/202323h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
15/12/202323h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VYNEVYNE Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:VYNE

Kürzlich von Ihnen besucht

COIN
ADAUSD
Cardano
COIN
SOLUSD
Solana
CCOM
US100
US Tech 100
NYSE
MCD
McDonalds
NYSE
MRK
Merck
NYSE
NKE
Nike
USOTC
BASFY
BASF (QX)
TG
ALV
Allianz
CCOM
US500
US 500
COIN
DOGEUSD
Dogecoin
FX
EURJPY
Euro vs Yen
TG
DTE
Deutsche Telekom
NYSE
KO
Coca Cola
COIN
AVAXUSD
Avalanche
TG
DBK
Deutsche Bank
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten

BLACK FRIDAY

ADVFN

Seit 25 Jahren im Geschäft 1999-2024

Sparen Sie bis zu 60%* für Euronext Level 2

1 Jahr 40%, 2 Jahre 50% und *3 Jahre 60%

*Über 3 Jahre 1094.04€, jetzt nur noch 437.62€